Skip to content

Loading your page…

Active substance · J07BN01

*sarscov s-protein mrna,

On 1 register3 medicines1 company

See every medicineAsk Osler about it

Classification

Anatomical main groupJAnti-infectives for systemic use
Therapeutic subgroupJ07
Pharmacological subgroupJ07B
Chemical subgroupJ07BN
Chemical substanceJ07BN01Covid-19, rna-based vaccine

Where it is registered

Each register with its number of medicines and a few of them.

Canada
Health Canada · 3 medicines

All medicines with *sarscov s-protein mrna,

Every register, a page at a time. Strengths and packs are on each medicine’s page.

8 results

Medicine	Register	Strength	Form	Status	Holder
Spikevax	Canada	0.1 MG / ML	Dispersion	Marketed	Moderna Biopharma Canada Corporation
Spikevax	Canada	50 MCG / 0.5 ML	Dispersion	Marketed	Moderna Biopharma Canada Corporation
Comirnaty	Canada	30 MCG / 0.3 ML	Suspension	Marketed	Biontech Manufacturing GMBH
Comirnaty	Canada	30 MCG / 0.3 ML	Suspension	Marketed	Biontech Manufacturing GMBH
Comirnaty	Canada	10 MCG / 0.3 ML	Suspension	Marketed	Biontech Manufacturing GMBH
Spikevax	Canada	25 MCG / 0.25 ML	Dispersion	Authorised	Moderna Biopharma Canada Corporation
Comirnaty	Canada	3 MCG / 0.3 ML	Suspension	Authorised	Biontech Manufacturing GMBH
Mnexspike	Canada	10 MCG / 0.2 ML	Dispersion	Authorised	Moderna Biopharma Canada Corporation

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.